For most of recorded history, the greatest threat to the armed forces has come not from battlefield injuries but rather from infectious diseases, for which effective drugs were needed.
A message to the ASPET membership from Executive Officer Dave Jackson as 2025 draws to a close.
Building Something That Lasts: The Unusual Journey of Dr. D. Fernando Estrada, Who Put His Inner Gremlin on a Shelf; ASPET Welcomes New Members.
Honoring ASPET members who have passed.
Year in Review: ASPET’s Government Affairs and Science Policy. 2025 has been a transformative year for the science community. It changed and reshaped much of how we engage with policy and advocacy in ways that will live through the annals of time.
In Industry Insights, members of ASPET’s Industry Science Committee discuss the intersection of pharmacology and industry, private sector highlights, and how the industry and membership can support each other.
A showcase of early-career scientists—what drives them and why pharmacology is important to them.
ASPET’s Editors-in-Chief each selected an article from their journals, published in 2025, to be marked as free-to-read for the month of December. We invite you to explore and share the following research with your colleagues.
An interview with three distinguished members of ASPET about the society, and how it helped them navigate their careers. As our field adapts to new technologies, unpredictable federal policies, and evolving academic structures, ASPET must similarly adapt to best serve our members. As these three interviews with distinguished ASPET members makes clear, change is something that every scientist must expect, and membership in ASPET can be an invaluable aid in both developing career paths and furthering research.




